More information:
Toni K Choueiri et al, Belzutifan plus cabozantinib for patients with advanced clear cell renal cell carcinoma previously treated with immunotherapy: an open-label, single-arm, phase 2 study, The Lancet Oncology (2023). DOI: 10.1016/S1470-2045(23)00097-9
healthmedicinet
Daily News and Tips